Botai is engaged in the manufacture and sale of collagen injectable fillers, it received the first ever domestic production license for its collagen (brand name “Fillderm”) in May 2012. Botai is also exploring the possibilities of leveraging on Lansen’s infrastructure to distribute its collagen fillers and create synergies to tap into the potential within the cosmeceutical market in China.